Researchers are developing what they hope will be the first successful vaccine against the highly contagious and difficult-to ...

We recently published a list of 10 Best Depressed Stocks To Buy Heading into 2025. In this article, we are going to take a ...

The discovery of the first mRNA-stabilizing substance could pave the way for groundbreaking advancements in the development ...

Study reveals single-chain mRNA vaccines confer 100% protection against lethal mpox challenge in mice, marking a significant ...

Moderna is focusing on respiratory vaccines to sustain revenue streams amid COVID-19 declines. See more on MRNA stock and its ...

Researchers evaluated protection conferred by a single COVID-19 mRNA vaccine dose vs a 2-dose series in the setting of high preexisting SARS-CoV-2 immunity.

An 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are ...

In an era where viral outbreaks can escalate into global pandemics with alarming speed, the ability to quickly develop new ...

The jab uses mRNA technology to tell the immune system to recognise a ‘foreign’ protein on viruses and mount an attack.

The late-stage trial will recruit about 25,000 people around the world to test the new vaccine from Moderna.View on euronews ...

We recently compiled a list of the 10 Worst Performing NASDAQ Stocks in 2024. In this article, we are going to take a look at ...

At IDWeek 2024, Moderna presented interim results from an ongoing Phase I/II dose-ranging trial for mRNA-1403, a vaccine ...